Insulin glargine

被引：159
作者：
Bolli, GB [1 ]
Owens, DR
机构：
[1] Univ Perugia, Dept Internal Med, I-06126 Perugia, Italy
[2] Cardiff Univ, Diabet Res Unit, Cardiff CF4 4XN, S Glam, Wales
来源：
LANCET | 2000年 / 356卷 / 9228期
关键词：
D O I：
10.1016/S0140-6736(00)02546-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：443 / 445
页数：3
相关论文
共 14 条
[1]   The long acting human insulin analog HOE 901:: Characteristics of insulin signalling in comparison to Asp(B10) and regular insulin [J].
Berti, L ;
Kellerer, M ;
Bossenmaier, B ;
Seffer, E ;
Seipke, G ;
Häring, HU .
HORMONE AND METABOLIC RESEARCH, 1998, 30 (03) :123-129
[2]   Insulin analogues and their potential in the management of diabetes mellitus [J].
Bolli, GB ;
Di Marchi, RD ;
Park, GD ;
Pramming, S ;
Koivisto, VA .
DIABETOLOGIA, 1999, 42 (10) :1151-1167
[3]  
Bolli GB, 1999, J PEDIATR ENDOCR MET, V12, P737
[4]   Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo [J].
Heinemann, L ;
Linkeschova, R ;
Rave, K ;
Hompesch, B ;
Sedlak, M ;
Heise, T .
DIABETES CARE, 2000, 23 (05) :644-649
[5]   Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens [J].
Jehle, PM ;
Micheler, C ;
Jehle, DR ;
Breitig, D ;
Boehm, BB .
LANCET, 1999, 354 (9190) :1604-1607
[6]   Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use [J].
Kurtzhals, P ;
Schäffer, L ;
Sorensen, A ;
Kristensen, C ;
Jonassen, I ;
Schmid, C ;
Trüb, T .
DIABETES, 2000, 49 (06) :999-1005
[7]  
Lepore M, 1999, DIABETES, V48, pA97
[8]  
OWENS DR, 1999, DIABETES CURRENT PER
[9]   CONTINUOUS SUBCUTANEOUS INSULIN INFUSION - APPROACH TO ACHIEVING NORMOGLYCAEMIA [J].
PICKUP, JC ;
KEEN, H ;
PARSONS, JA ;
ALBERTI, KGMM .
BRITISH MEDICAL JOURNAL, 1978, 1 (6107) :204-207
[10]  
Pieber T, 1998, DIABETES, V47, pA62
12